Chapter 10 — Case Study 2: Mustard Gas, Nitrogen Mustards, and the Birth of Chemotherapy
How an $S_N2$-active poison from World War I became the first family of cancer drugs in 1947 — and why the same chemistry that destroys lung tissue also destroys cancer cells.
1. The molecule
Sulfur mustard is a small organic molecule with the formula $(ClCH_2CH_2)_2S$ — two β-chloroethyl groups attached to a central sulfur. It is a viscous, oily yellow liquid at room temperature with a faint smell of garlic or horseradish (hence "mustard"). It is heavier than air and tends to pool in low-lying areas — trenches, foxholes, basements.
Sulfur mustard was first synthesized in 1860 by the German chemist Frederick Guthrie and characterized in detail by Victor Meyer in 1886. It was used as a chemical warfare agent at scale by Germany at Ypres in July 1917 (giving rise to the alternative name "yperite"). Both sides used it in the final year of World War I; an estimated 1.3 million casualties resulted from chemical agents, with sulfur mustard accounting for the majority.
Its effects are horrific: severe blistering of skin within hours, conjunctivitis and corneal damage that can blind, respiratory tract burns, and — over days to weeks — pulmonary edema, sloughing of mucosal tissue, and death from respiratory failure or secondary infections. Sulfur mustard causes about 5% acute mortality but ~80% morbidity, with many casualties living long with permanent disability.
Why is this small molecule so destructive? The answer is $S_N2$ chemistry.
2. The mechanism: intramolecular cyclization first
A casual look at sulfur mustard suggests it is a normal alkyl chloride and should be only moderately reactive. The key observation is that sulfur mustard reacts much faster than its monocompound cousins (like 2-chloroethyl methyl sulfide). The reason is anchimeric (neighboring-group) assistance:
Step 1: The sulfur atom (with two lone pairs) attacks the carbon bearing chlorine in an intramolecular $S_N2$. The result is a three-membered ring sulfonium ion (an episulfonium), with the chloride departing as Cl⁻.
ClCH2CH2-S-CH2CH2Cl → ClCH2CH2-S(+) + Cl-
\ /
CH2-CH2 (3-mem ring)
This intramolecular attack has a strong rate enhancement (typical 10⁵–10⁶ relative to intermolecular) because the nucleophile is held close to the electrophile by the molecular geometry.
Step 2: The episulfonium is highly strained (3-member ring) and highly electrophilic (positive charge on S). Any biological nucleophile — a DNA base nitrogen, a glutathione thiol, an amino acid amine — attacks the cation. The reaction opens the ring and adds the nucleophile to one of the two carbons.
[episulfonium]+ + Nu: → Nu-CH2-CH2-S-CH2CH2Cl
The product still has one β-chloroethyl group, which can repeat the cyclization-attack sequence. So sulfur mustard can attack two nucleophiles per molecule — and this is why it can cross-link DNA strands (one alkylation on each strand of the double helix) or cross-link DNA to protein.
3. Why cross-linking is so toxic
Cross-linking DNA between the two strands of the helix prevents the two strands from separating. DNA must separate during replication, transcription, and repair. Cross-linked DNA cannot: - Replicate (so the cell cannot divide). - Transcribe (so genes cannot be expressed). - Be repaired (the normal DNA repair machinery uses one strand as a template to fix the other).
For fast-dividing cells (skin epidermal cells, mucosa, bone marrow, intestinal epithelium), the inability to replicate is rapidly catastrophic. Within hours, cells start dying en masse. The exposed tissue blisters, sloughs, becomes secondary-infected, and may die outright.
For slow-dividing cells, the damage is less acute but still serious. Mutations and chromosome breakages accumulate. Long-term cancer risk increases.
The chemistry of how a small chlorinated sulfide destroys lung and skin is just $S_N2$ at scale. Tens of thousands of mustard gas molecules per cell, each one capable of two alkylation events, all happening on a millisecond timescale.
4. The medical observation that changed history
In December 1943, the SS John Harvey — a US merchant ship carrying mustard gas as part of allied chemical-weapon contingency — was destroyed in an air raid on Bari, Italy. The ship's cargo released a toxic cloud over the harbor. About a thousand servicemen and civilians were exposed; most died within weeks.
A US Army colonel, Stewart Alexander, was sent to investigate. Examining bodies and survivors, he noticed something strange: the white blood cells (especially lymphocytes) of mustard-exposed patients were dramatically depleted. Lymph nodes were drained. Bone marrow was suppressed.
Alexander wondered: if mustard preferentially kills white blood cells, could it be useful against blood cancers (which are uncontrolled white-blood-cell proliferation)?
Two pharmacologists at Yale, Louis Goodman and Alfred Gilman, had been thinking along the same lines (their work was classified during the war). In 1942, before Bari, they had treated a patient with non-Hodgkin lymphoma — a usually-fatal blood cancer of B lymphocytes — with nitrogen mustard (mechlorethamine, a less-volatile derivative of sulfur mustard with a nitrogen instead of sulfur center: $(ClCH_2CH_2)_2NCH_3$). The patient's tumors regressed for weeks before the cancer recurred and killed him.
This was the first documented chemotherapy. It worked because cancer cells, like the bone-marrow cells that mustard kills, are rapidly dividing. The same DNA-cross-linking that makes mustard gas a weapon makes it a cytotoxic agent against fast-growing tumors.
5. The nitrogen mustards — first chemotherapy drugs
By 1947, the wartime work of Goodman and Gilman was declassified and published. Mechlorethamine (the first chemo drug; trade name Mustargen) became the first FDA-approved cytotoxic chemotherapy. The mechanism is exactly the same as sulfur mustard, but with a nitrogen replacing the sulfur.
The reaction:
Step 1: Nitrogen attacks intramolecularly to form an aziridinium (3-member ring with N+).
Step 2: A DNA base nitrogen attacks the aziridinium, opening the ring and alkylating the DNA.
Step 3: The remaining β-chloroethyl group does the same, alkylating a second DNA site.
Result: cross-linked DNA. Cell cycle arrest. Cell death.
The clinical drugs that followed include: - Cyclophosphamide (Cytoxan): a prodrug — its β-chloroethyl groups are masked by a phosphoramide that liver enzymes activate. Selective for tumor cells partly because tumor cells lack the enzyme that detoxifies the active form. - Ifosfamide: a structural analog with slightly different selectivity. - Melphalan: phenylalanine + nitrogen mustard, used in multiple myeloma and ovarian cancer. - Chlorambucil: butyric acid + nitrogen mustard, used in chronic lymphocytic leukemia. - Bendamustine: a more recent agent combining nitrogen mustard reactivity with a benzimidazole moiety.
Each of these acts by the same fundamental mechanism: aziridinium formation, then DNA alkylation, then cross-linking, then cell death.
6. The selectivity question
Why does nitrogen mustard kill tumor cells more than normal cells, given that the chemistry is non-selective?
Three contributing factors: 1. Tumor cells divide faster than most normal cells. Slow-dividing cells (most adult tissue) can repair some DNA damage before having to replicate; fast-dividing cells cannot. 2. Tumor cells often have defective DNA repair. Common mutations in p53, BRCA1/2, and other repair-related genes make tumor cells less able to fix the damage that mustards inflict. 3. Pharmacokinetics and dosing. Treatment is given at doses where toxicity is manageable; even some collateral damage to normal tissue (myelosuppression, hair loss, nausea) is accepted as the cost of treating the cancer.
The selectivity is relative, not absolute. Standard chemotherapy with nitrogen mustards causes substantial side effects, especially bone-marrow suppression. Modern oncology has developed more selective drugs, but nitrogen mustards remain in use for blood cancers and some solid tumors where their efficacy outweighs the side effects.
7. The lesson
Sulfur mustard and nitrogen mustards are simple organic molecules. Their toxicity comes from a single $S_N2$ event (preceded by intramolecular cyclization to make an exceptional electrophile). The same chemistry that destroys exposed skin in war kills cancer cells in chemotherapy.
The history shows two things: 1. Mechanism is what matters. Whether the reaction destroys lung tissue or saves a cancer patient depends only on context, not chemistry. 2. An understanding of mechanism enables medicine. Goodman and Gilman didn't have access to a structural biology lab in 1943. They knew the reaction; they hypothesized the application; they tested it. The first chemotherapy drug came from understanding $S_N2$ at the level you are learning right now.
Modern oncology has moved toward more targeted approaches (kinase inhibitors, antibody drug conjugates, immunotherapy). But cytotoxic chemotherapy, descended from nitrogen mustards, remains the foundation of cancer treatment for many disease types. The chemistry is Chapter 10.
The story also reminds us of a hard truth: the same molecule, the same mechanism, can serve very different purposes. The chemistry is morally neutral; the application is not.
Further reading: - Christakis, N. A. (2011). The collective wisdom of military medicine. N. Engl. J. Med. 365, 1058. (Bari incident.) - DeVita, V. T., and Chu, E. (2008). A history of cancer chemotherapy. Cancer Res. 68, 8643. - Gilman, A. (1963). The initial clinical trial of nitrogen mustard. Am. J. Surg. 105, 574. (Goodman and Gilman's own retrospective.) - Lawley, P. D., and Phillips, D. H. (1996). DNA adducts from chemotherapeutic agents. Mutat. Res. 355, 13. - Watson, J. T., and Sparkman, O. D. (2007). Introduction to Mass Spectrometry. (For analyzing mustard-DNA adducts.)